ANA ALZAMORA MONDRAGON: Open Payments
NPI 1417423856 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$374 in 17 payments from 11 companies in 2025. Trend: 2023 $572 · 2024 $501 · 2025 $374
Food & beverage: $374
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 2 | $53 |
| Daiichi Sankyo Inc. | 2 | $49 |
| Exact Sciences Corporation | 2 | $40 |
| Lilly USA, LLC | 2 | $38 |
| Dexcom, Inc. | 2 | $37 |
| PFIZER INC. | 2 | $36 |
| CeQur Corporation | 1 | $32 |
| Dynavax Technologies Corporation | 1 | $29 |
| AstraZeneca Pharmaceuticals LP | 1 | $25 |
| Medtronic, Inc. | 1 | $19 |
Products named: INJECTAFER, KISUNLA, Dexcom G6 Transmitter, NURTEC ODT, CeQur Simplicity, Heplisav-B, UPTRAVI, OPSUMIT.
Industry payments across CA — which companies pay providers there.
